Video

Dr. Ranjith Ramasamy discusses research evaluating COVID-19 and erectile dysfunction

Author(s):

Urology Times staff

“I think doctors should be aware that if men do complain of erectile dysfunction after [having] COVID-19 that it could be because of underlying endothelial dysfunction and underlying vasculature issues,” Ramasamy says.

In this interview, Ranjith Ramasamy, MD, discusses the recent World Journal of Men’s Health study, “COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis,” for which he served as senior author. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.

Related Videos
Doctor giving a consultation to a patient and explaining medical informations and diagnosis | Image Credit: © Pcess609 - stock.adobe.com
Man talking with doctor | Image Credit: © RFBSIP - stock.adobe.com
Landon Trost, MD, answers a question during a Zoom video interview
Helen L. Bernie, DO, MPH, answers a question during a Zoom video interview
John P. Mulhall, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Helen L. Bernie, DO, MPH, answers a question during a Zoom video interview
Related Content
Long-term data point to durable efficacy of Optilume for urethral strictures
May 13th 2025

Long-term data point to durable efficacy of Optilume for urethral strictures

Hannah Clarke
The freedom from re-intervention rate was 71%.
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
May 17th 2025

Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

Amy M. Pearlman, MD Alex Tatem, MD
Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
Du Geon Moon, MD, PhD | Credit: Korea University College of Medicine
April 27th 2025

Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation

Patrick Campbell
A phase 3 trial reveals a combination therapy for premature ejaculation significantly enhances treatment outcomes.
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
May 4th 2025

Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25

Amy M. Pearlman, MD Kevin C. Zorn, MD, FRCSC, FACS
Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.
Label change for testosterone: Implications for urologists, prescribers, and patients
April 9th 2025

Label change for testosterone: Implications for urologists, prescribers, and patients

Hannah Clarke
In February 2025, the FDA recommended a removal of the black box warning related to an increased risk of adverse cardiovascular outcomes for all testosterone products. This recommendation has important implications for urologists and the patients they treat.
Exercise may improve erectile function in men with prostate cancer
March 17th 2025

Exercise may improve erectile function in men with prostate cancer

Hannah Clarke
“The study suggests that exercise would be an effective intervention for men with prostate cancer who express concern about sexual dysfunction, and that exercise medicine should be considered a key part of their treatment,” says Daniel Galvão, PhD.
© 2025 MJH Life Sciences

All rights reserved.